-
1
-
-
0037847545
-
Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion
-
Abrahamyan, L. G., R. M. Markosyan, J. P. Moore, F. S. Cohen, and G. B. Melikyan. 2003. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion. J. Virol. 77:5829-5836.
-
(2003)
J. Virol.
, vol.77
, pp. 5829-5836
-
-
Abrahamyan, L.G.1
Markosyan, R.M.2
Moore, J.P.3
Cohen, F.S.4
Melikyan, G.B.5
-
2
-
-
0027223565
-
Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries
-
Barbas, C. F., III, et al. 1993. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J. Mol. Biol. 230:812-823.
-
(1993)
J. Mol. Biol.
, vol.230
, pp. 812-823
-
-
Barbas III, C.F.1
-
3
-
-
80055113924
-
-
Keystone Symp. X6, HIV Vaccines, Keystone, CO, 27 March to 2 April 2006
-
Bibollet-Ruche, F., et al. 2006. Detection of novel neutralizing antibody responses to the membrane proximal external region (MPER) or gp41 following infection by HIV-1 subtypes A, B, C, D, F, G, H, CRF01, CRF02, or CRF11. Keystone Symp. X6, HIV Vaccines, Keystone, CO, 27 March to 2 April 2006.
-
(2006)
Detection of novel neutralizing antibody responses to the membrane proximal external region (MPER) or gp41 following infection by HIV-1 subtypes A, B, C, D, F, G, H, CRF01, CRF02, or CRF11
-
-
Bibollet-Ruche, F.1
-
4
-
-
69549086342
-
Specificities of broadly neutralizing anti-HIV-1 sera
-
Binley, J. M. 2009. Specificities of broadly neutralizing anti-HIV-1 sera. Curr. Opin. HIV AIDS 4:364-372.
-
(2009)
Curr. Opin. HIV AIDS
, vol.4
, pp. 364-372
-
-
Binley, J.M.1
-
5
-
-
0038076112
-
Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions
-
Binley, J. M., et al. 2003. Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions. J. Virol. 77:5678-5684.
-
(2003)
J. Virol.
, vol.77
, pp. 5678-5684
-
-
Binley, J.M.1
-
6
-
-
0030897105
-
Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1
-
Binley, J. M., et al. 1997. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J. Virol. 71:2799-2809.
-
(1997)
J. Virol.
, vol.71
, pp. 2799-2809
-
-
Binley, J.M.1
-
7
-
-
56449131391
-
Profiling the specificity of neutralizing antibodies in a large panel of HIV-1 plasma samples from subtype B and C chronic infections
-
Binley, J. M., et al. 2008. Profiling the specificity of neutralizing antibodies in a large panel of HIV-1 plasma samples from subtype B and C chronic infections. J. Virol. 82:11651-11668.
-
(2008)
J. Virol.
, vol.82
, pp. 11651-11668
-
-
Binley, J.M.1
-
8
-
-
8644251891
-
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
-
Binley, J. M., et al. 2004. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78:13232-13252.
-
(2004)
J. Virol.
, vol.78
, pp. 13232-13252
-
-
Binley, J.M.1
-
9
-
-
38849205377
-
Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41
-
Blish, C. A., M. A. Nguyen, and J. Overbaugh. 2008. Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41. PLoS Med. 5:e9.
-
(2008)
PLoS Med
, vol.5
-
-
Blish, C.A.1
Nguyen, M.A.2
Overbaugh, J.3
-
10
-
-
80052938385
-
Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors
-
Bonsignori, M., et al. 2011. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J. Virol. 85:9998-10009.
-
(2011)
J. Virol.
, vol.85
, pp. 9998-10009
-
-
Bonsignori, M.1
-
11
-
-
49149118421
-
Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection
-
Bunnik, E. M., L. Pisas, A. C. van Nuenen, and H. Schuitemaker. 2008. Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. J. Virol. 82:7932-7941.
-
(2008)
J. Virol.
, vol.82
, pp. 7932-7941
-
-
Bunnik, E.M.1
Pisas, L.2
van Nuenen, A.C.3
Schuitemaker, H.4
-
12
-
-
1542317452
-
HIV vaccine design and the neutralizing antibody problem
-
Burton, D. R., et al. 2004. HIV vaccine design and the neutralizing antibody problem. Nat. Immunol. 5:233-236.
-
(2004)
Nat. Immunol.
, vol.5
, pp. 233-236
-
-
Burton, D.R.1
-
13
-
-
0027985431
-
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
-
Burton, D. R., et al. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024-1027.
-
(1994)
Science
, vol.266
, pp. 1024-1027
-
-
Burton, D.R.1
-
14
-
-
12444291017
-
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
-
Calarese, D. A., et al. 2003. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300:2065-2071.
-
(2003)
Science
, vol.300
, pp. 2065-2071
-
-
Calarese, D.A.1
-
15
-
-
0031025113
-
Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor
-
Cheng-Mayer, C., R. Liu, N. R. Landau, and L. Stamatatos. 1997. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor. J. Virol. 71:1657-1661.
-
(1997)
J. Virol.
, vol.71
, pp. 1657-1661
-
-
Cheng-Mayer, C.1
Liu, R.2
Landau, N.R.3
Stamatatos, L.4
-
16
-
-
34247559067
-
Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies
-
Choudhry, V., et al. 2007. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies. Virology 363:79-90.
-
(2007)
Virology
, vol.363
, pp. 79-90
-
-
Choudhry, V.1
-
17
-
-
79956222491
-
Acute HIV-1 infection
-
Cohen, M. S., G. M. Shaw, A. J. McMichael, and B. F. Haynes. 2011. Acute HIV-1 infection. N. Engl. J. Med. 364:1943-1954.
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 1943-1954
-
-
Cohen, M.S.1
Shaw, G.M.2
McMichael, A.J.3
Haynes, B.F.4
-
18
-
-
77649318846
-
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals
-
Corti, D., et al. 2010. Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS One 5:e8805.
-
(2010)
PLoS One
, vol.5
-
-
Corti, D.1
-
19
-
-
45049083040
-
Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization
-
Crooks, E. T., et al. 2008. Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization. Virology 377:364-378.
-
(2008)
Virology
, vol.377
, pp. 364-378
-
-
Crooks, E.T.1
-
20
-
-
34548577658
-
A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120
-
Crooks, E. T., et al. 2007. A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. Virology 366:245-262.
-
(2007)
Virology
, vol.366
, pp. 245-262
-
-
Crooks, E.T.1
-
21
-
-
33646720281
-
Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization
-
Crooks, E. T., et al. 2005. Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. Hum. Antibodies 14:101-113.
-
(2005)
Hum. Antibodies
, vol.14
, pp. 101-113
-
-
Crooks, E.T.1
-
22
-
-
0026675432
-
Spectrotype of anti-gp120 antibodies remains stable during the course of HIV disease
-
D'Amelio, R., et al. 1992. Spectrotype of anti-gp120 antibodies remains stable during the course of HIV disease. J. Acquir. Immune Defic. Syndr. 5:930-935.
-
(1992)
J. Acquir. Immune Defic. Syndr.
, vol.5
, pp. 930-935
-
-
D'Amelio, R.1
-
23
-
-
59749089778
-
Human immunodeficiency virus type 2 (HIV-2)/ HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma
-
Davis, K. L., et al. 2009. Human immunodeficiency virus type 2 (HIV-2)/ HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma. J. Virol. 83:1240-1259.
-
(2009)
J. Virol.
, vol.83
, pp. 1240-1259
-
-
Davis, K.L.1
-
24
-
-
20844448731
-
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
-
Decker, J. M., et al. 2005. Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J. Exp. Med. 201:1407-1419.
-
(2005)
J. Exp. Med.
, vol.201
, pp. 1407-1419
-
-
Decker, J.M.1
-
25
-
-
34249950588
-
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors
-
Dhillon, A. K., et al. 2007. Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors. J. Virol. 81:6548-6562.
-
(2007)
J. Virol.
, vol.81
, pp. 6548-6562
-
-
Dhillon, A.K.1
-
26
-
-
77957198704
-
Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16
-
Doores, K. J., and D. R. Burton. 2010. Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16. J. Virol. 84:10510-10521.
-
(2010)
J. Virol.
, vol.84
, pp. 10510-10521
-
-
Doores, K.J.1
Burton, D.R.2
-
27
-
-
73949084963
-
Breadth of human immunodeficiency virusspecific neutralizing activity in sera: clustering analysis and association with clinical variables
-
Doria-Rose, N. A., et al. 2010. Breadth of human immunodeficiency virusspecific neutralizing activity in sera: clustering analysis and association with clinical variables. J. Virol. 84:1631-1636.
-
(2010)
J. Virol.
, vol.84
, pp. 1631-1636
-
-
Doria-Rose, N.A.1
-
28
-
-
84887212581
-
International network for comparison of HIV neutralization assays: the NeutNet report
-
Fenyo, E. M., et al. 2009. International network for comparison of HIV neutralization assays: the NeutNet report. PLoS One 4:e4505.
-
(2009)
PLoS One
, vol.4
-
-
Fenyo, E.M.1
-
29
-
-
57349165849
-
Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120
-
Forsman, A., et al. 2008. Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120. J. Virol. 82:12069-12081.
-
(2008)
J. Virol.
, vol.82
, pp. 12069-12081
-
-
Forsman, A.1
-
30
-
-
0030897825
-
Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
-
Fouts, T. R., J. M. Binley, A. Trkola, J. E. Robinson, and J. P. Moore. 1997. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 71: 2779-2785.
-
(1997)
J. Virol.
, vol.71
, pp. 2779-2785
-
-
Fouts, T.R.1
Binley, J.M.2
Trkola, A.3
Robinson, J.E.4
Moore, J.P.5
-
31
-
-
0030018993
-
Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G The WHO and NIAID Networks for HIV Isolation and Characterization
-
Gao, F., et al. 1996. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization. J. Virol. 70:1651-1667.
-
(1996)
J. Virol.
, vol.70
, pp. 1651-1667
-
-
Gao, F.1
-
32
-
-
78349299783
-
Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies
-
Gnanakaran, S., et al. 2010. Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies. PLoS Comput. Biol. 6:e1000955.
-
(2010)
PLoS Comput. Biol.
, vol.6
-
-
Gnanakaran, S.1
-
33
-
-
16244419386
-
Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles
-
Gorny, M. K., et al. 2005. Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles. J. Virol. 79:5232-5237.
-
(2005)
J. Virol.
, vol.79
, pp. 5232-5237
-
-
Gorny, M.K.1
-
34
-
-
79955389756
-
The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4' T cell decline and high viral load during acute infection
-
Gray, E. S., et al. 2011. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4' T cell decline and high viral load during acute infection. J. Virol. 85:4828-4840.
-
(2011)
J. Virol.
, vol.85
, pp. 4828-4840
-
-
Gray, E.S.1
-
35
-
-
70350320582
-
Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region
-
Gray, E. S., et al. 2009. Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region. J. Virol. 83:11265-11274.
-
(2009)
J. Virol.
, vol.83
, pp. 11265-11274
-
-
Gray, E.S.1
-
36
-
-
79960413187
-
Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizingantibody response in an HIV-1 subtype C-infected individual
-
Gray, E. S., et al. 2011. Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizingantibody response in an HIV-1 subtype C-infected individual. J. Virol. 85:7719-7729.
-
(2011)
J. Virol.
, vol.85
, pp. 7719-7729
-
-
Gray, E.S.1
-
37
-
-
39749136530
-
4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membraneproximal external region-neutralizing antibody response
-
Gray, E. S., et al. 2008. 4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membraneproximal external region-neutralizing antibody response. J. Virol. 82:2367-2375.
-
(2008)
J. Virol.
, vol.82
, pp. 2367-2375
-
-
Gray, E.S.1
-
38
-
-
34249940652
-
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection
-
Gray, E. S., et al. 2007. Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. J. Virol. 81:6187-6196.
-
(2007)
J. Virol.
, vol.81
, pp. 6187-6196
-
-
Gray, E.S.1
-
39
-
-
69249208675
-
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors
-
Gray, E. S., et al. 2009. Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors. J. Virol. 83:8925-8937.
-
(2009)
J. Virol.
, vol.83
, pp. 8925-8937
-
-
Gray, E.S.1
-
40
-
-
79551556431
-
Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinant
-
Guenaga, J., et al. 2011. Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinant. PLoS One 6:e16074.
-
(2011)
PLoS One
, vol.6
-
-
Guenaga, J.1
-
41
-
-
0028670687
-
Analysis of B cell repertoire specific to the neutralizing epitopes of glycoprotein 120 in HIV-infected individuals
-
Hariharan, K., P. L. Nara, L. A. Shabazz, J. A. McCutchan, and C. Y. Kang. 1994. Analysis of B cell repertoire specific to the neutralizing epitopes of glycoprotein 120 in HIV-infected individuals. AIDS Res. Hum. Retroviruses 10:1629-1637.
-
(1994)
AIDS Res. Hum. Retroviruses
, vol.10
, pp. 1629-1637
-
-
Hariharan, K.1
Nara, P.L.2
Shabazz, L.A.3
McCutchan, J.A.4
Kang, C.Y.5
-
42
-
-
0035132287
-
SHIVSF162P3
-
SHIVSF162P3. J. Virol. 75:1990-1995.
-
(2001)
J. Virol.
, vol.75
, pp. 1990-1995
-
-
Harouse, J.M.1
-
43
-
-
21344434534
-
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies
-
Haynes, B. F., et al. 2005. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308:1906-1908.
-
(2005)
Science
, vol.308
, pp. 1906-1908
-
-
Haynes, B.F.1
-
44
-
-
68349160853
-
Effective, low titer, antibody protection against low dose repeated mucosal SHIV challenge in macaques
-
Hessell, A. J., et al. 2009. Effective, low titer, antibody protection against low dose repeated mucosal SHIV challenge in macaques. Nat. Med. 15: 951-954.
-
(2009)
Nat. Med.
, vol.15
, pp. 951-954
-
-
Hessell, A.J.1
-
45
-
-
67249131966
-
Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers
-
Hessell, A. J., et al. 2009. Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. PLoS Pathog. 5:e1000433.
-
(2009)
PLoS Pathog
, vol.5
-
-
Hessell, A.J.1
-
47
-
-
77954110431
-
Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
-
Hioe, C. E., et al. 2010. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes. PLoS One 5:e10254.
-
(2010)
PLoS One
, vol.5
-
-
Hioe, C.E.1
-
48
-
-
34249952292
-
Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies
-
Kraft, Z., et al. 2007. Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies. J. Virol. 81:6402-6411.
-
(2007)
J. Virol.
, vol.81
, pp. 6402-6411
-
-
Kraft, Z.1
-
49
-
-
0141521564
-
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1
-
Labrijn, A. F., et al. 2003. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1. J. Virol. 77:10557-10565.
-
(2003)
J. Virol.
, vol.77
, pp. 10557-10565
-
-
Labrijn, A.F.1
-
50
-
-
23244434512
-
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
-
Li, M., et al. 2005. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79:10108-10125.
-
(2005)
J. Virol.
, vol.79
, pp. 10108-10125
-
-
Li, M.1
-
51
-
-
33751224478
-
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa
-
Li, M., et al. 2006. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J. Virol. 80: 11776-11790.
-
(2006)
J. Virol.
, vol.80
, pp. 11776-11790
-
-
Li, M.1
-
52
-
-
34948854718
-
Broad HIV-1 neutralization mediated by CD4 binding site antibodies
-
Li, Y., et al. 2007. Broad HIV-1 neutralization mediated by CD4 binding site antibodies. Nat. Med. 13:1032-1034.
-
(2007)
Nat. Med.
, vol.13
, pp. 1032-1034
-
-
Li, Y.1
-
53
-
-
58149517700
-
Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals
-
Li, Y., et al. 2009. Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals. J. Virol. 83:1045-1059.
-
(2009)
J. Virol.
, vol.83
, pp. 1045-1059
-
-
Li, Y.1
-
54
-
-
64949164763
-
High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies
-
Liao, H. X., et al. 2009. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J. Virol. Methods 158:171-179.
-
(2009)
J. Virol. Methods
, vol.158
, pp. 171-179
-
-
Liao, H.X.1
-
55
-
-
0037029924
-
Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1
-
Mascola, J. R. 2002. Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1. Vaccine 20:1922-1925.
-
(2002)
Vaccine
, vol.20
, pp. 1922-1925
-
-
Mascola, J.R.1
-
56
-
-
0037393393
-
HIV-1 nature's master of disguise
-
Mascola, J. R., and D. C. Montefiori. 2003. HIV-1: nature's master of disguise. Nat. Med. 9:393-394.
-
(2003)
Nat. Med.
, vol.9
, pp. 393-394
-
-
Mascola, J.R.1
Montefiori, D.C.2
-
58
-
-
0033951746
-
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
-
Mascola, J. R., et al. 2000. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6:207-210.
-
(2000)
Nat. Med.
, vol.6
, pp. 207-210
-
-
Mascola, J.R.1
-
59
-
-
72949117233
-
The immune response during acute HIV-1 infection: clues for vaccine development
-
McMichael, A. J., P. Borrow, G. D. Tomaras, N. Goonetilleke, and B. F. Haynes. 2010. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 10:11-23.
-
(2010)
Nat. Rev. Immunol.
, vol.10
, pp. 11-23
-
-
McMichael, A.J.1
Borrow, P.2
Tomaras, G.D.3
Goonetilleke, N.4
Haynes, B.F.5
-
60
-
-
79551518897
-
Characteristics of the earliest cross-neutralizing antibody response to HIV-1
-
Mikell, I., et al. 2011. Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog. 7:e1001251.
-
(2011)
PLoS Pathog
, vol.7
-
-
Mikell, I.1
-
61
-
-
40849136223
-
The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design
-
Montero, M., N. E. van Houten, X. Wang, and J. K. Scott. 2008. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol. Mol. Biol. Rev. 72:54-84.
-
(2008)
Microbiol. Mol. Biol. Rev.
, vol.72
, pp. 54-84
-
-
Montero, M.1
van Houten, N.E.2
Wang, X.3
Scott, J.K.4
-
62
-
-
33144486096
-
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1
-
Moore, P. L., et al. 2006. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J. Virol. 80:2515-2528.
-
(2006)
J. Virol.
, vol.80
, pp. 2515-2528
-
-
Moore, P.L.1
-
63
-
-
38849090714
-
The C3-V4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection
-
Moore, P. L., et al. 2008. The C3-V4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection. J. Virol. 82:1860-1869.
-
(2008)
J. Virol.
, vol.82
, pp. 1860-1869
-
-
Moore, P.L.1
-
64
-
-
79952579682
-
Potent and broad neutralization of HIV-1 subtype C viruses by plasma antibodies targeting a quaternary epitope including residues in the V2 loop
-
Moore, P. L., et al. 2011. Potent and broad neutralization of HIV-1 subtype C viruses by plasma antibodies targeting a quaternary epitope including residues in the V2 loop. J. Virol. 85:3128-3141.
-
(2011)
J. Virol.
, vol.85
, pp. 3128-3141
-
-
Moore, P.L.1
-
65
-
-
70349686331
-
Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection
-
Moore, P. L., et al. 2009. Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog. 5:e1000598.
-
(2009)
PLoS Pathog
, vol.5
-
-
Moore, P.L.1
-
66
-
-
79551700244
-
A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection
-
Musich, T., et al. 2011. A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection. J. Virol. 85:2397-2405.
-
(2011)
J. Virol.
, vol.85
, pp. 2397-2405
-
-
Musich, T.1
-
67
-
-
0027378573
-
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
-
Muster, T., et al. 1993. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:6642-6647.
-
(1993)
J. Virol.
, vol.67
, pp. 6642-6647
-
-
Muster, T.1
-
68
-
-
71049141219
-
Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1
-
Nandi, A., et al. 2010. Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1. Virology 396:339-348.
-
(2010)
Virology
, vol.396
, pp. 339-348
-
-
Nandi, A.1
-
69
-
-
34247106331
-
An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10
-
Nelson, J. D., et al. 2007. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10. J. Virol. 81:4033-4043.
-
(2007)
J. Virol.
, vol.81
, pp. 4033-4043
-
-
Nelson, J.D.1
-
70
-
-
77957940271
-
Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus
-
O'Rourke, S. M., et al. 2010. Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus. J. Virol. 84:11200-11209.
-
(2010)
J. Virol.
, vol.84
, pp. 11200-11209
-
-
O'Rourke, S.M.1
-
71
-
-
0011993562
-
A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope
-
Palker, T. J., et al. 1987. A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc. Natl. Acad. Sci. U. S. A. 84:2479-2483.
-
(1987)
Proc. Natl. Acad. Sci. U. S. A.
, vol.84
, pp. 2479-2483
-
-
Palker, T.J.1
-
72
-
-
34250027638
-
Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis
-
Pantophlet, R., R. O. Aguilar-Sino, T. Wrin, L. A. Cavacini, and D. R. Burton. 2007. Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis. Virology 364:441-453.
-
(2007)
Virology
, vol.364
, pp. 441-453
-
-
Pantophlet, R.1
Aguilar-Sino, R.O.2
Wrin, T.3
Cavacini, L.A.4
Burton, D.R.5
-
73
-
-
0034864776
-
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
-
Parren, P. W., et al. 2001. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 75:8340-8347.
-
(2001)
J. Virol.
, vol.75
, pp. 8340-8347
-
-
Parren, P.W.1
-
74
-
-
33846172297
-
Rational modifications of HIV-1 envelope glycoproteins for immunogen design
-
Phogat, S., and R. Wyatt. 2007. Rational modifications of HIV-1 envelope glycoproteins for immunogen design. Curr. Pharm. Des. 13:213-227.
-
(2007)
Curr. Pharm. Des.
, vol.13
, pp. 213-227
-
-
Phogat, S.1
Wyatt, R.2
-
75
-
-
0037389643
-
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
-
Richman, D. D., T. Wrin, S. J. Little, and C. J. Petropoulos. 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. U. S. A. 100:4144-4149.
-
(2003)
Proc. Natl. Acad. Sci. U. S. A.
, vol.100
, pp. 4144-4149
-
-
Richman, D.D.1
Wrin, T.2
Little, S.J.3
Petropoulos, C.J.4
-
77
-
-
34249789875
-
Unique mutational patterns in the envelope α2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1
-
Rong, R., et al. 2007. Unique mutational patterns in the envelope α2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. J. Virol. 81:5658-5668.
-
(2007)
J. Virol.
, vol.81
, pp. 5658-5668
-
-
Rong, R.1
-
78
-
-
70349695689
-
Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways
-
Rong, R., et al. 2009. Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog. 5:e1000594.
-
(2009)
PLoS Pathog
, vol.5
-
-
Rong, R.1
-
79
-
-
0036637385
-
The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120
-
Sanders, R. W., et al. 2002. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76:7293-7305.
-
(2002)
J. Virol.
, vol.76
, pp. 7293-7305
-
-
Sanders, R.W.1
-
80
-
-
51149120614
-
Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection
-
Santiago, M. L., et al. 2008. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 321:1343-1346.
-
(2008)
Science
, vol.321
, pp. 1343-1346
-
-
Santiago, M.L.1
-
81
-
-
58149487645
-
Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection
-
Sather, D. N., et al. 2009. Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection. J. Virol. 83:757-769.
-
(2009)
J. Virol.
, vol.83
, pp. 757-769
-
-
Sather, D.N.1
-
82
-
-
77952516203
-
Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects
-
Sather, D. N., and L. Stamatatos. 2010. Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects. Vaccine 28(Suppl. 2): B8-B12.
-
(2010)
Vaccine
, vol.28
, Issue.SUPPL. 2
-
-
Sather, D.N.1
Stamatatos, L.2
-
83
-
-
0028999803
-
Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer
-
Sattentau, Q. J., and J. P. Moore. 1995. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182:185-196.
-
(1995)
J. Exp. Med.
, vol.182
, pp. 185-196
-
-
Sattentau, Q.J.1
Moore, J.P.2
-
84
-
-
34247636624
-
Exploiting the defensive sugars of HIV-1 for drug and vaccine design
-
Scanlan, C. N., J. Offer, N. Zitzmann, and R. A. Dwek. 2007. Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature 446:1038-1045.
-
(2007)
Nature
, vol.446
, pp. 1038-1045
-
-
Scanlan, C.N.1
Offer, J.2
Zitzmann, N.3
Dwek, R.A.4
-
85
-
-
18244422922
-
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of →2 mannose residues on the outer face of gp120
-
Scanlan, C. N., et al. 2002. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of →2 mannose residues on the outer face of gp120. J. Virol. 76:7306-7321.
-
(2002)
J. Virol.
, vol.76
, pp. 7306-7321
-
-
Scanlan, C.N.1
-
86
-
-
9144222999
-
The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12
-
Scanlan, C. N., et al. 2003. The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12. Adv. Exp. Med. Biol. 535:205-218.
-
(2003)
Adv. Exp. Med. Biol.
, vol.535
, pp. 205-218
-
-
Scanlan, C.N.1
-
87
-
-
63849131879
-
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
-
Scheid, J. F., et al. 2009. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458:636-640.
-
(2009)
Nature
, vol.458
, pp. 636-640
-
-
Scheid, J.F.1
-
88
-
-
0036315133
-
Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein
-
Schulke, N., et al. 2002. Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein. J. Virol. 76:7760-7776.
-
(2002)
J. Virol.
, vol.76
, pp. 7760-7776
-
-
Schulke, N.1
-
89
-
-
73949127978
-
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies
-
Seaman, M. S., et al. 2010. Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J. Virol. 84:1439-1452.
-
(2010)
J. Virol.
, vol.84
, pp. 1439-1452
-
-
Seaman, M.S.1
-
90
-
-
34548695901
-
Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens
-
Seaman, M. S., et al. 2007. Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens. Virology 367:175-186.
-
(2007)
Virology
, vol.367
, pp. 175-186
-
-
Seaman, M.S.1
-
91
-
-
0037317611
-
Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity
-
Sharon, M., et al. 2003. Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity. Structure 11:225-236.
-
(2003)
Structure
, vol.11
, pp. 225-236
-
-
Sharon, M.1
-
92
-
-
77950537428
-
Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution
-
Shen, X., et al. 2010. Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution. Proc. Natl. Acad. Sci. U. S. A. 107:5972-5977.
-
(2010)
Proc. Natl. Acad. Sci. U. S. A.
, vol.107
, pp. 5972-5977
-
-
Shen, X.1
-
93
-
-
64049092486
-
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth
-
Shen, X., et al. 2009. In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth. J. Virol. 83:3617-3625.
-
(2009)
J. Virol.
, vol.83
, pp. 3617-3625
-
-
Shen, X.1
-
94
-
-
67650453747
-
Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified using a high-throughput neutralization assay together with an analytical selection algorithm
-
Simek, M. D., et al. 2009. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified using a high-throughput neutralization assay together with an analytical selection algorithm. J. Virol. 83:7337-7348.
-
(2009)
J. Virol.
, vol.83
, pp. 7337-7348
-
-
Simek, M.D.1
-
95
-
-
0032169683
-
Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication
-
Stamatatos, L., M. Wiskerchen, and C. Cheng-Mayer. 1998. Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication. AIDS Res. Hum. Retroviruses 14:1129-1139.
-
(1998)
AIDS Res. Hum. Retroviruses
, vol.14
, pp. 1129-1139
-
-
Stamatatos, L.1
Wiskerchen, M.2
Cheng-Mayer, C.3
-
97
-
-
57349127300
-
Initial B-cell responses to transmitted human immunodeficiency virus type 1 virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia
-
Tomaras, G. D., et al. 2008. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82:12449-12463.
-
(2008)
J. Virol.
, vol.82
, pp. 12449-12463
-
-
Tomaras, G.D.1
-
98
-
-
9044241681
-
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
-
Trkola, A., et al. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1100-1108.
-
(1996)
J. Virol.
, vol.70
, pp. 1100-1108
-
-
Trkola, A.1
-
99
-
-
0345471066
-
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
-
Veazey, R. S., et al. 2003. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat. Med. 9:343-346.
-
(2003)
Nat. Med.
, vol.9
, pp. 343-346
-
-
Veazey, R.S.1
-
100
-
-
77953543379
-
Rational antibody-based HIV-1 vaccine design: current approaches and future directions
-
Walker, L. M., and D. R. Burton. 2010. Rational antibody-based HIV-1 vaccine design: current approaches and future directions. Curr. Opin. Immunol. 22:358-366.
-
(2010)
Curr. Opin. Immunol.
, vol.22
, pp. 358-366
-
-
Walker, L.M.1
Burton, D.R.2
-
102
-
-
70349887757
-
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target
-
Walker, L. M., et al. 2009. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326:285-289.
-
(2009)
Science
, vol.326
, pp. 285-289
-
-
Walker, L.M.1
-
103
-
-
77958115264
-
A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals
-
Walker, L. M., et al. 2010. A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLoS Pathog. 6:e1001028.
-
(2010)
PLoS Pathog
, vol.6
-
-
Walker, L.M.1
-
104
-
-
0037456827
-
Antibody neutralization and escape by HIV-1
-
Wei, X., et al. 2003. Antibody neutralization and escape by HIV-1. Nature 422:307-312.
-
(2003)
Nature
, vol.422
, pp. 307-312
-
-
Wei, X.1
-
105
-
-
80052942203
-
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing
-
Wu, X., et al. 2011. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333:1593-1602.
-
(2011)
Science
, vol.333
, pp. 1593-1602
-
-
Wu, X.1
-
106
-
-
77954920017
-
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1
-
Wu, X., et al. 2010. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329:856-861.
-
(2010)
Science
, vol.329
, pp. 856-861
-
-
Wu, X.1
-
107
-
-
0036436313
-
Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies
-
Xiang, S. H., N. Doka, R. K. Choudhary, J. Sodroski, and J. E. Robinson. 2002. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies. AIDS Res. Hum. Retroviruses 18:1207-1217.
-
(2002)
AIDS Res. Hum. Retroviruses
, vol.18
, pp. 1207-1217
-
-
Xiang, S.H.1
Doka, N.2
Choudhary, R.K.3
Sodroski, J.4
Robinson, J.E.5
-
108
-
-
33644752818
-
Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma
-
Yuste, E., et al. 2006. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma. J. Virol. 80:3030-3041.
-
(2006)
J. Virol.
, vol.80
, pp. 3030-3041
-
-
Yuste, E.1
-
109
-
-
77954943648
-
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01
-
Zhou, T., et al. 2010. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329:811-817.
-
(2010)
Science
, vol.329
, pp. 811-817
-
-
Zhou, T.1
-
110
-
-
0034759882
-
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41
-
Zwick, M. B., et al. 2001. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75:10892-10905.
-
(2001)
J. Virol.
, vol.75
, pp. 10892-10905
-
-
Zwick, M.B.1
|